Insider trade

10% owner sold ~$16.8M of ROIV shares in the open market

Traded Dec 11, 2025 · Filed Dec 16, 2025

Why it stands out

A big owner of Roivant Sciences sold $16.8M of Roivant Sciences shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

10% owner$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$16,752,433

Shares × reported transaction price

Timing vs results

31 days after results of Nov 10, 2025, 57 days before results of Feb 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−0.9%	+2.8%	−3.7%
30 days	+1.9%	+3.0%	−1.1%
90 days	+24.7%	−0.1%	+24.8%
180 days	+32.3%	+12.4%	+19.9%

Past results only. Not a forecast.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.35 to $22.05, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

9mo ago

Derivative exercise or conversion — not an open-market buy.

Automatic sale9mo ago

9mo ago

Derivative exercise or conversion — not an open-market buy.